<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Moderate <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (<z:chebi fb="8" ids="35738">MAA</z:chebi>) in children is a rare, idiopathic condition of bone marrow insufficiency that can resolve spontaneously, persist for months or years, or progress to severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the rate of progression to SAA </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We reviewed the records of 136 children referred for evaluation of <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> from 1978 to 2002 at St </plain></SENT>
<SENT sid="3" pm="."><plain>Jude Children's Research Hospital </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="8" ids="35738">MAA</z:chebi> was defined by a <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypocellular bone marrow</z:e> (&lt;50%) and 2 or 3 cytopenias (absolute neutrophil count &lt;1,500/mm(3), absolute reticulocyte count &lt;40,000/mm(3), platelet count &lt;100,000/mm(3)) lasting at least 6 weeks </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Twenty-four patients met the criteria for <z:chebi fb="8" ids="35738">MAA</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>At a median follow-up of 66 months (range, 10-293), 16 patients (67%) progressed to SAA, 5 (21%) had persistent <z:chebi fb="8" ids="35738">MAA</z:chebi>, and 3 (12%) had complete resolution of <z:chebi fb="8" ids="35738">MAA</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>No risk factors for progression could be identified </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: When childhood <z:chebi fb="8" ids="35738">MAA</z:chebi> is treated with supportive care alone, 2/3 of patients progress to SAA </plain></SENT>
</text></document>